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Background: The calcium in the artery was thought to be the result of the imbalance or dysregulation of the promoter and 
inhibitor cytokines influenced by various subclinical and clinical conditions. This study aimed to investigate the interaction 
between central obesity, as an early subclinical condition, also known as a chronic low grade inflammation condition and 
coronary artery calcium (CAC) in non-diabetic population including the underlying pathomechanisms of a CAC in the early 
stage of atherosclerosis. 
Materials and Methods: This was a cross-sectional pathway analysis study enrolling 60 central obesity non-diabetic men 
that underwent coronary calcium score scan, anthropometrics and biomarker assays.
Results:  There was a positive correlation between increasing free leptin index/adiponectin (FLI/A) ratio and CAC (r=0.297; 
p<0.05). There was a positive correlation between increasing FLI/A ratio and plasma high sensitive C-reactive protein (hs-
CRP) (r=0.318; p<0.05). Plasma hs-CRP and bone morphogenetic protein-2 (BMP-2)-matrix gla protein (MGP) dysregulation 
were positively correlated (r=0.221; p<0.05) after adjusted to risk factors including insulin resistance, hypertension, age, 
and dyslipidemia.
Conclusion: The study found that one of the pathways involved in CAC in the centrally obese non-diabetic male is might be 
due to an increase of free leptin and decrease of adiponectin. The free leptin and adiponection ratio also increased hs-CRP, 
which partially correlated to the dysregulation of BMP-2 and MGP. 
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Introduction
The  mechanism  involved  in  atherosclerosis  consists 
of local vascular injury, inflammation, oxidative stress 
and vascular calcification.1 Vascular calcification at the 
early stage of atherosclerosis was demonstrated in recent 
studies and are associated with cardiovascular mortality and 
morbidity.2,3  The  degree  of  calcification  was  associated 
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with local vascular inflammation and progression of 
atherosclerosis.1,4 
 Adipocyte and macrophages in fat tissues secrete 
cytokines that are involved in osteogenic mineralization 
of atherosclerotic process which in turn stimulates the 
secretion of hepatic C-reactive protein (CRP), was thought 
to be central in the relationship between inflammation 
and coronary calcification.5-8 Vascular calcification is 
a result of the imbalance between factors that promote 
calcification and mineralization inhibitor, these are bone 
morphogenetic protein-2 (BMP-2), leptin, oxidative stress, 
hyperphosphatemia, hyperparathyroidism, and vitamin 
D. While factors that inhibit mineralization includes 
matrix-carboxyglutamic acid gla protein (MGP), fetuin, 
adiponectin, and osteopontin.9 
 Adiponectin is an anti-inflammatory and anti-
atherogenic substance which secretion is decreased 
in obesity.10 Plasma adiponectin concentration was 
independently associated with coronary artery calcium 
(CAC) score. Increased circulating leptin concentration is a 
marker of leptin resistance and is commonly found in obese 
patients.11 
 Free leptin index (FLI) which is the ratio of leptin 
and soluble leptin receptor (SLR), is thought to be a more 
accurate marker of leptin function.12 SLR is the main 
binding protein for leptin in human blood, and therefore is 
capable of pivotally modulating its bioavailability.13 Plasma 
leptin:adiponectin concentration ratio (L:A ratio) was 
thought to be an atherosclerotic index in type 2 DM patients 
and also a stronger indicator of carotid intimal media 
thickness (IMT).14-16 However, the data regarding the role 
of FLI/adiponectin (FLI/A) ratio is scarce. CAC score or 
degree of coronary calcification is an independent predictor 
for coronary artery disease.17 
 BMP-2 promotes calcification because it is a powerful 
osteogenic protein needed for differentiation of osteoblast 
and bone formation is also central in the mechanism of 
vascular calcification.18 MGP is known as cartilage and 
vascular calcification inhibitor by regulating BMP-2.19
 The mechanism of vascular calcification in non-
diabetic population with central obesity remained elusive. 
This study aimed to investigate the interaction between 
central obesity and CAC in non-diabetic population including 
the underlying pathomechanism. The pathomechanism that 
will be studied includes marker of adipokine dysfunction 
(leptin, free leptin index, adiponectin), inflammation (hs-
CRP), and bone regulator protein (BMP-2 and MGP). 
 We decided to exclude female patients from this study 
because the prevalence of coronary calcification and CAC 
score were lower in female compared to male20, a higher 
leptin concentration in female, and lower adiponectin 




In this observational cross-sectional study, patients who 
were referred to the radiology department of Siloam 
Hospitals Lippo Village, Tangerang, Indonesia for 
Calcium score assessment using Dual Source 64-slice 
Computed Tomography scan during 2010-2011 period 
were consecutively enrolled. Our study was approved by 
the Institutional ethics committee at Faculty of medicine, 
Hasanuddin University, Makassar, Indonesia (Ethical 
approval recommendation letter No.2062/H04.8.4.5.31/
PP36-KOMETIK/2010). 
 Inclusion criteria were as follows: (1) male >45 years 
old; (2) waist circumference >90 cm; (3) no prior history of 
diabetes, chronic kidney disease, or transaminitis; (4) CAC 
score >10; (5) no prior history of coronary stent or coronary 
bypass grafting; (6) no current anticoagulant regiment; (7) 
absence of acute inflammatory states; and (8) willing to 
participate in study. All patients who fulfill the inclusion 
criteria were enrolled. The calculated sample size was 52.78 
subjects, and rounded up to 60 subjects. 
Dual Source 64 Slice Computed Tomography
CAC scoring of the subjects were performed on Dual Source 
64 Slice Computed tomography (Siemens Healthineers, 
Erlangen, Germany) with prospective electrocardiographic 
gating method, and subjects holding their breath for 7 
seconds, by sequential data acquisition with slice thickness 
of 3 mm. 
Subjects Characteristics 
(n=60) n (%)
Smoker  9 (15.0%)
Exercise 34 (56.7%)
Hypertension 36 (60.0%)
Hypertension therapy 25 (41.7%)
Statin therapy 22 (36.7%)
Table 1. Subjects' characteristic.
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Subjects Characteristics 
(n=60) Minimum Maximum Median Mean±SD
Age (years old) 45 70 55 55.20±6.51 
Height (cm) 155 180 167 167.0±5.9 
Weight (kg) 62 112 80 80.3±10.8 
BMI (kg/m2) 23.2 37.5 28.1 28.8±3.3 
NC (cm) 35 49.5 40 40.2±2.9 
AC (cm) 90 125 99 101.0±7.9 
SBP (mmHg ) 100 183 130 129.3±14.8 
DBP (mmHg ) 60 100 80 82.0±8.6 
PP (mmHg ) 30 103 42.5 47.3±12.3 
MAP (mmHg ) 80 120 96.7 97.7±9.4 
FBG (mg/dL) 81 123 98 99.4±10.5 
HOMA IR 0.46 6.42 2.7 2.89±1.45 
TC (mg/dL) 97 286 206.5 207.9±39.5 
HDL (mg/dL) 26 61 41.5 42.2±7.7 
LDL (mg/dL) 42 205 130.5 131.2±36.6 
TG (mg/dL) 39 396 131 146±74 
CAC (Agatston Unit) 11 770 117.2 173.6±177.8 
Adiponectin (ng/mL) 1218 7311 3356.4 3627.9 ±1256.7 
Leptin (ng/mL) 2.2 31.1 9.4 10.8±6.4 
SLR (ng/mL) 11.5 34.8 21.53 21.94±5.5 
FLI 0.1 1.8 0.5 0.6±0.4 
Hs-CRP (mg/dL) 0.2 9.6 1.5 2.3±2.1 
BMP-2 (pg/dL) 142 4095 1796 1736.6±1015.7 
MGP (pg/dL) 56941 198915.5 91356.1 100407.0±25916.7 
Table 2. Clinical variables of subjects.
BMI: body mass index; NC: neck circumference; AC: abdominal circumference; SBP: systolic blood 
pressure; DBP: diastolic blood pressure; PP: pulse pressure; MAP: mean arterial pressure; FBG: fasting 
blood glucose; HOMA IR: homeostasis model assessment of insulin resistance; TC: total cholesterol; 
HDL: high density lipoprotein cholesterol; LDL: low density lipoprotein; TG: triglyceride; CAC: coronary 
artery calcium; SLR: soluble leptin receptor; FLI: free leptin index; hs-CRP: high sensitive C-reactive 
protein; BMP2: bone morphogenetic protein; MGP: matrix gla protein.
CAC Scoring 
CAC  scoring was calculated by modified Agatston score with 
detection threshold of 130HU (Hounsfield Unit), performed 
using semi-automatical software (Syngo Calcium Scoring, 
Siemens Medical Solutions, Erlangen, Germany). Each data 
was determined by a certified radiology technician and a 
certified radiologist physician.
Biomarkers Assay
Serum level of adiponectin, leptin, SLR, BMP-2 were 
measured using enzyme-linked immunosorbent assay 
(ELISA) method, while serum level of MGP was using 
quantitative enzyme immunoassay (EIA) method. 
Fasting insulin concentration was measured using 
immunochemiluminescent method. Laboratory tests of 
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the subjects were done by Prodia Laboratories (PT Prodia 
Widyahusada, Jakarta, Indonesia).
 FLI is defined as a ratio of plasma leptin over plasma 
SLR levels, with cut-off point derived from median, the 
normal values of  adiponectin is 3-30 µg/mL, leptin 2-8 µg/
mL, SLR 81.2±143.2 ng/mL, and the cut-off points of BPM-
2 and MGP are derived from  median.
Statistical Analysis
Data analyses using univariate, bivariate and multivariate 
approaches were performed. Results were narrated and 
illustrated using tables and figures. Statistical tests that were 
performed includes: (1) descriptive analysis using univariate 
methods to compute minimum and maximum values, 
median, mean and standard of deviation; (2) normalcy 
test; (3) Pearson and Spearman correlation tests; (4) partial 
correlation test of parametric and non-parametric values; 
(5) cross-tabulations. All analyses were performed with the 
IBM SPSS version 15 on windows (IBM Inc, Armonk, NY, 
USA).
Results
There were 60 subjects that fulfilled the inclusion criteria. 
The characteristics of these subjects were summarized in 
Table 1 and Table 2. Mean CAC score was 173.6±177.8 and 
mean FLI was 0.6±0.4. 
Correlation 
Coefficient (r) p -value
FLI/Adiponectin 0.297 <0.05 
Hs-CRP 0.077 >0.05 
BMP-2 and MGP dysregulation 0.015 >0.05 
CAC (n=60)
Variable
Table 3. Correlation between adipokine, inflammation, 























CAC: coronary artery calcium; SLR: soluble leptin receptor; 
FLI: free leptin index; hs-CRP: high sensitive C-reactive 
protein; BMP-2: bone morphogenetic protein; MGP: matrix 
gla protein. Tested with Spearman one-tailed bivariate 
analysis.
Figure 1. Correlation between variables 
in this study. FLI: free leptin index; A: 
adiponectin; hs-CRP: high sensitivity 
C-reactive protein; BMP-2: bone 
morphogenetic protein-2; MGP: matrix 
gla-protein; CAC: coronary artery calcium. 
Tested with partial bivariate analysis 
Spearman one-tailed; *Significant correlation 
at p<0,05; Adjusted to insulin resistance, 
age, hypertension, and dyslipidemia.
 There was a positive correlation between increasing 
FLI/A ratio and CAC (r=0.297; p<0.05).  However, there 
was no significant correlation between plasma hs-CRP and 
BMP-2-MGP dysregulation with CAC (Table 3, Figure 
1). Plasma hs-CRP and BMP-2-MGP dysregulation were 
positively correlated (r=0.221; p<0.05) after adjustment of 
age, hypertension, insulin resistance and dyslipidemia and 
there was no significant correlation between FLI/A ratio 
and BMP-2-MGP dysregulation. There was a significant 
positive correlation between FLI/A ratio and hs-CRP 
(r=0.318; p<0.05).
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Figure 2. Proposed mechanism of CAC caused by central obesity. 1Cbfa1: core-binding factor alpha-1; BMP: bone 
morphogenetic protein; MGP: matrix gla protein; MSX2: homeobox protein MSX-2; Ox-LDL: oxidized low-density 
lipoprotein; ROS: reactive oxygen species; VSMC: vascular smooth muscle; CKD: chronic kidney disease.
Discussion
A positive correlation between FLI/A ratio and CAC in this 
study is in agreement with a cohort study that reports an 
inverse relationship between adiponectin and progression 
of CAC in both type 1 diabetic and non-diabetics.23 
Leptin regulates osteoblastic differentiation, vascular cell 
calcification, and the presence of leptin receptor on the 
calcified vascular cells.24 This might also stem from the 
fact that leptin triggers vascular inflammation by activating 
immune cells, increasing CRP and oxidative stress, 
and directly changed vascular conditions by initiating 
proliferation and migration of smooth muscle cells causing 
calcification and reducing the compliance of vessel walls.25 
Obesity is a low-grade chronic inflammatory condition 
caused by a change in adipocyte and macrophage function 
resulting in adipokine hypersecretion which is an atherogenic, 
pro-inflammatory, and pro-diabetic followed by reduced 
production of anti-inflammatory adiponectin.26 Another 
important finding is that FLI/A ratio and hs-CRP were 
positively correlated in our study, adipokine was associated 
with chronic low-grade inflammation.27 A study showed that 
high serum leptin increased the coronary artery endothelial 
production of CRP suggesting its pro-atherogenicity.28 There 
was an inverse relationship between adiponectin and plasma 
CRP in both plasma and adipocytes.29 
 Our study showed that there is no direct correlation 
between increased FLI/A ratio and dysregulation of BMP-2-
MGP balance. A positive correlation was found between hs-
CRP as inflammatory markers and dysregulation of BMP-2-
MGP balance after adjusted to risk factors including insulin 
resistance, hypertension, age, and dyslipidemia. This result 
may be due to BMP-2 induced by inflammation.30
 No significant correlation between either hs-CRP or 
dysregulation of BMP-2-MGP balance with CAC score 
in this study might be due to the dynamic biological 
phenomenon between promoting and inhibitory factors 
affecting CAC. Hence, it is difficult to get a static and 
absolute variable in one period. A proposed mechanism of 
CAC caused by central obesity is shown in Figure 2.
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Conclusion
In this study, we found the pathways involved in CAC in the 
centrally obese non-diabetic males were the increase of free 
leptin and a decrease of adiponectin, which correlated with 
the degree of coronary artery calcification. The increased 
of free leptin and adiponectin ratio was also leading to 
the increase of low grade inflammation hs-CRP, which 
eventually increases the promoter of calcification (BMP2) 
and reduces the inhibitor of calcification (MGP). These 
dynamic pathways were influenced by risk factors such as 
insulin resistance, age, hypertension and dyslipidemia.
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